A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) is a late-stage biopharmaceutical company focused on discovering, developing, and seeking to commercialize innovative therapies for diseases with significant unmet medical needs. The company's development programs...
Reviva Pharma (Nasdaq: RVPH) is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families. This company...
Reviva (Nasdaq: RVPH) is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families. This fireside chat was...
Reviva Pharmaceuticals Holdings (Nasdaq: RVPH) is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their...
This company webcast features Reviva Pharmaceuticals Holdings (Nasdaq: RVPH). Reviva is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens...
Reviva (Nasdaq: RVPH) is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families. Reviva’s current...
During this fireside chat webcast, we welcome Reviva Pharmaceuticals, ticker symbol RVPH on the NASDAQ. Joining us today from the company is Lax Bhat, Reviva's Chief Executive Officer. Also joining us is Jim Molloy, Senior Research Analyst with Alliance Global...
During this fireside chat, we welcome Reviva Pharmaceuticals, ticker, RVPH on the NASDAQ, and their CEO, Dr. Lax Bhat. Reviva is a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system...
This panel presentation features executives from three different companies that are looking to advance innovations in healthcare, each of them with ongoing or planned Phase 3 trials here. We've titled the panel, Phase 3 Drugs to Watch. Hosted by Lytham Partners...
Reviva is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families. Reviva’s current pipeline focuses...